Research graph
References from Burden of respiratory syncytial virus (RSV) hospitalizations among adults aged 60 years or more in Brazil: A retrospective surveillance database analysis (2013–2024). Local targets link to admitted publications; unresolved targets remain external evidence.
Respiratory Syncytial Virus Infection: An Update
10.1007/s12098-023-04613-w · 2023 · External reference
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
10.1016/s0140-6736(17)30938-8 · 2017 · External reference
Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies
10.7150/ijbs.64762 · 2021 · External reference
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries
10.1183/16000617.0105-2022 · 2022 · External reference
Respiratory Syncytial Virus Epidemiology and Clinical Burden in High-Risk and ≥ 50-Year-Old Adults in Low- to Middle-Income Countries: An Artificial-Intelligence-Enabled Systematic Literature Review
10.1007/s40121-025-01220-4 · 2025 · External reference
Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis
10.1111/irv.13031 · 2023 · External reference
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus - RSV-NET, 12 States, July 2022-June 2023
10.15585/mmwr.mm7240a1 · 2023 · External reference
Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study
10.1016/j.cmi.2023.03.003 · 2023 · External reference
Systematic review on respiratory syncytial virus epidemiology in adults and the elderly in Latin America
10.1016/j.ijid.2019.10.025 · 2020 · External reference
Unresolved reference
External reference
Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations
10.1590/0074-02760150341 · 2016 · External reference
Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries
10.3390/idr16040057 · 2024 · External reference
Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel
10.1080/21645515.2024.2388943 · 2024 · External reference
Non-communicable diseases, sociodemographic vulnerability and the risk of mortality in hospitalised children and adolescents with COVID-19 in Brazil: a cross-sectional observational study
2021 · External reference
First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality
2022 · External reference
Casos graves de vírus sincicial respiratório em anos de pandemia: uma análise retrospectiva da base de dados do SIVEP-GRIPE no Brasil (2020-2022)
10.1016/j.bjid.2023.103129 · 2023 · External reference
Prevalence and seasonal distribution of viral etiology of respiratory tract infections in inpatients and outpatients of the pediatric population: 10 year follow-up
10.24953/turkjped.2018.06.004 · 2018 · External reference
Global distribution of respiratory syncytial virus A and B infections: a systematic review
10.1080/20477724.2022.2038053 · 2022 · External reference
Resurgence of human respiratory syncytial virus during COVID-19 pandemic in Southern Brazil
10.1002/jmv.29551 · 2024 · External reference
Respiratory Syncytial Virus Seasonality: A Global Overview
10.1093/infdis/jiy056 · 2018 · External reference
Unresolved reference
2015 · External reference
Outcomes of SARS-CoV-2 and Seasonal Viruses Among 2 Million Adults Hospitalized for Severe Acute Respiratory Infection During the COVID-19 Pandemic in Brazil
10.1093/infdis/jiae295 · 2024 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Temporal trend of mortality and hospitalization for chronic kidney disease in adults from Northern Brazil
10.1097/md.0000000000029702 · 2022 · External reference
In-hospital outcomes of rhinovirus and respiratory syncytial virus infections: a retrospective cohort study
10.1007/s44370-025-00013-0 · 2025 · External reference
Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: a systematic analysis
10.1186/s12916-023-02932-5 · 2023 · External reference
Economic burden of respiratory syncytial virus infection in adults: a systematic literature review
10.1080/13696998.2023.2213125 · 2023 · External reference
Economic burden of respiratory syncytial virus disease in Latin America: A systematic review
10.1080/21645515.2024.2381298 · 2024 · External reference
Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
10.1001/jamanetworkopen.2021.41779 · 2021 · External reference
Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic
10.1038/s41467-024-47757-9 · 2024 · External reference
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults
10.1001/jamanetworkopen.2024.4954 · 2024 · External reference
Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?
10.3390/v15091848 · 2023 · External reference
Burden of respiratory syncytial virus in older adults in Brazil: insights from national surveillance data for the 2022-2023 period
2025 · External reference
Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
10.1007/s40121-023-00802-4 · 2023 · External reference
Clinical characteristics, predictors, and performance of case definition-Interim results from the WHO global respiratory syncytial virus surveillance pilot
10.1111/irv.12688 · 2020 · External reference
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease
10.1001/jamanetworkopen.2024.50832 · 2024 · External reference
Unresolved reference
2024 · External reference
Unresolved reference
External reference
Unresolved reference
2025 · External reference
Unresolved reference
2023 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
External reference
WHO position paper on immunization to protect infants against respiratory syncytial virus disease
2025 · External reference
Unresolved reference
2023 · External reference
Unresolved reference
2025 · External reference
Maternal RSV vaccination to protect infants in Brazil: a model-based cost-effectiveness analysis for incorporation into the National Immunisation Program
2025 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2023 · External reference
Respiratory syncytial virus infection in the modern era
10.1097/qco.0000000000000917 · 2023 · External reference
Public health impact of the adjuvanted RSVPreF3 vaccine in adults aged 60 years and older: results from a modeling study in six Latin American countries
10.1080/14760584.2025.2539892 · 2025 · External reference
Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
10.1001/jamanetworkopen.2021.41779 · ExternalCitation · doi-reference
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults
10.1001/jamanetworkopen.2024.4954 · ExternalCitation · doi-reference
Estimated Vaccine Effectiveness for Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease
10.1001/jamanetworkopen.2024.50832 · ExternalCitation · doi-reference
Resurgence of human respiratory syncytial virus during COVID-19 pandemic in Southern Brazil
10.1002/jmv.29551 · ExternalCitation · doi-reference
Respiratory Syncytial Virus Infection: An Update
10.1007/s12098-023-04613-w · ExternalCitation · doi-reference
Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
10.1007/s40121-023-00802-4 · ExternalCitation · doi-reference
Respiratory Syncytial Virus Epidemiology and Clinical Burden in High-Risk and ≥ 50-Year-Old Adults in Low- to Middle-Income Countries: An Artificial-Intelligence-Enabled Systematic Literature Review
10.1007/s40121-025-01220-4 · ExternalCitation · doi-reference
In-hospital outcomes of rhinovirus and respiratory syncytial virus infections: a retrospective cohort study
10.1007/s44370-025-00013-0 · ExternalCitation · doi-reference
Casos graves de vírus sincicial respiratório em anos de pandemia: uma análise retrospectiva da base de dados do SIVEP-GRIPE no Brasil (2020-2022)
10.1016/j.bjid.2023.103129 · ExternalCitation · doi-reference
Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study
10.1016/j.cmi.2023.03.003 · ExternalCitation · doi-reference
Systematic review on respiratory syncytial virus epidemiology in adults and the elderly in Latin America
10.1016/j.ijid.2019.10.025 · ExternalCitation · doi-reference
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
10.1016/s0140-6736(17)30938-8 · ExternalCitation · doi-reference
Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic
10.1038/s41467-024-47757-9 · ExternalCitation · doi-reference
Economic burden of respiratory syncytial virus infection in adults: a systematic literature review
10.1080/13696998.2023.2213125 · ExternalCitation · doi-reference
Public health impact of the adjuvanted RSVPreF3 vaccine in adults aged 60 years and older: results from a modeling study in six Latin American countries
10.1080/14760584.2025.2539892 · ExternalCitation · doi-reference
Global distribution of respiratory syncytial virus A and B infections: a systematic review
10.1080/20477724.2022.2038053 · ExternalCitation · doi-reference
Economic burden of respiratory syncytial virus disease in Latin America: A systematic review
10.1080/21645515.2024.2381298 · ExternalCitation · doi-reference
Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel
10.1080/21645515.2024.2388943 · ExternalCitation · doi-reference
Outcomes of SARS-CoV-2 and Seasonal Viruses Among 2 Million Adults Hospitalized for Severe Acute Respiratory Infection During the COVID-19 Pandemic in Brazil
10.1093/infdis/jiae295 · ExternalCitation · doi-reference
Respiratory Syncytial Virus Seasonality: A Global Overview
10.1093/infdis/jiy056 · ExternalCitation · doi-reference
Temporal trend of mortality and hospitalization for chronic kidney disease in adults from Northern Brazil
10.1097/md.0000000000029702 · ExternalCitation · doi-reference
Respiratory syncytial virus infection in the modern era
10.1097/qco.0000000000000917 · ExternalCitation · doi-reference
Clinical characteristics, predictors, and performance of case definition-Interim results from the WHO global respiratory syncytial virus surveillance pilot
10.1111/irv.12688 · ExternalCitation · doi-reference
Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis
10.1111/irv.13031 · ExternalCitation · doi-reference
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries
10.1183/16000617.0105-2022 · ExternalCitation · doi-reference
Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: a systematic analysis
10.1186/s12916-023-02932-5 · ExternalCitation · doi-reference
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus - RSV-NET, 12 States, July 2022-June 2023
10.15585/mmwr.mm7240a1 · ExternalCitation · doi-reference
Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations
10.1590/0074-02760150341 · ExternalCitation · doi-reference
Prevalence and seasonal distribution of viral etiology of respiratory tract infections in inpatients and outpatients of the pediatric population: 10 year follow-up
10.24953/turkjped.2018.06.004 · ExternalCitation · doi-reference
Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries
10.3390/idr16040057 · ExternalCitation · doi-reference
Clinical Characterization of Respiratory Syncytial Virus Infection in Adults: A Neglected Disease?
10.3390/v15091848 · ExternalCitation · doi-reference
Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies
10.7150/ijbs.64762 · ExternalCitation · doi-reference
